• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中药对儿童过敏性鼻炎鼻痒的疗效:一项系统评价和Meta分析

Efficacy of Chinese herbal medicine on nasal itching in children with allergic rhinitis: a systematic review and meta-analysis.

作者信息

Chen Yuhang, Wang Jie, Wu Liqun, Zhang Ye, Chen Hong, Zhang Ziwei

机构信息

The Second Clinical Medical College of Beijing University of Chinese Medicine, Dongfang Hospital of Beijing University of Chinese Medicine, Beijing, China.

The First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, China.

出版信息

Front Pharmacol. 2023 Aug 23;14:1240917. doi: 10.3389/fphar.2023.1240917. eCollection 2023.

DOI:10.3389/fphar.2023.1240917
PMID:37680707
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10482051/
Abstract

Allergic rhinitis is prevalent among children and can cause nasal itching, fatigue, and even hinder growth and development. The main discomfort symptom of allergic rhinitis is nasal itching. Clinical reports suggest that Chinese herbal medicine (CHM) is effective in allergy rhinitis treatment. Therefore, we evaluate the clinical efficacy of Chinese herbal medicine in treating nasal itching caused by allergic rhinitis in children. Nine databases, including PubMed, Embase, The Cochrane Library, Web of Science, China National Knowledge Infrastructure, Wan Fang Data, CQVIP, Chinese Biological Medicine, and ClinicalTrials.gov, were systematically searched from their inception until March 2023. Randomized controlled trials (RCTs) comparing the efficacy of Chinese herbal medicine, either alone or in combination with Western medicine, to Western medicine treatment or placebo intervention for treating allergic rhinitis in children were eligible for inclusion. The effectiveness of Chinese herbal medicines for nasal itching was mainly evaluated. The Risk of Bias tool 2.0 assessed the risk of bias. Statistical analysis using RevMan 5.3 and Stata/SE 12. The quality of evidence was evaluated by GRADEpro 3.6. Risk ratios (RR) with corresponding 95% confidence intervals (CI) were utilized to evaluate and present dichotomous data, while mean difference (MD) and standardized mean difference (SMD) were employed for continuous data. A fixed-effects model was applied in cases where the data exhibited homogeneity ( > 0.1, I2 < 50%), whereas a random-effects model was utilized for heterogeneous data. Statistical significance was determined by a -value <0.05. This study was conducted by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, and its review protocol was registered on the International Platform for Registered Systematic Reviews and Meta-Analysis Programs (INPLASY202340076). The review incorporated 23 studies. The meta-analysis indicated that herbal medicine was significantly related to the reduction of nasal itching (MD = -0.59, 95%CI: -0.94-0.24) and the increase of interleukin 10 level (SMD = 1.47, 95% CI: 0.90-2.05). Compared to Western medicine, the combining herbs and Western medicine showed better efficacy in relieving nasal itching, inhibiting immunoglobulin E, interleukin 4 and 33, enhancing interleukin 10, improving therapeutic efficiency, and reducing recurrent. Oral herbal medicine was more effective in treating nasal itching (MD = -0.45, 95% CI: -0.62-0.29). Combining oral and external herbal medicines was more efficient in treating nasal itching (MD = -0.44, 95% CI: -0.54-0.33), inhibiting immunoglobulin E, interleukin 4 (SMD = -0.87, 95% CI: -1.24-0.50) and 33 (SMD = -1.16, 95% CI: -1.54-0.77), and improving therapeutic efficiency. External herbal medicine did not show differences compared to Western medicines. Regarding safety, herbal medicine alone exhibited fewer adverse events than Western medicine; combining herbal and Western medicine showed no significant variation in adverse event incidence. Chinese herbal medicine (CHM) holds great potential in alleviating symptoms, modulating immune factors levels, and reducing relapse in pediatric rhinitis. Meanwhile, CHM is relatively safe. However, the efficacy and safety of CHM in treating pediatric rhinitis still need to be confirmed due to the inclusion of studies with low methodological quality, small sample sizes, and potential heterogeneity. More high-quality research is necessary to provide reliable evidence for the clinical application of CHM. : INPLASY.com, identifier INPLASY202340076.

摘要

变应性鼻炎在儿童中很常见,可引起鼻痒、疲劳,甚至阻碍生长发育。变应性鼻炎的主要不适症状是鼻痒。临床报告表明,中药在变应性鼻炎治疗中有效。因此,我们评估中药治疗儿童变应性鼻炎所致鼻痒的临床疗效。从创刊至2023年3月,系统检索了9个数据库,包括PubMed、Embase、Cochrane图书馆、Web of Science、中国知网、万方数据、维普资讯、中国生物医学数据库和ClinicalTrials.gov。比较中药单独或联合西药与西药治疗或安慰剂干预治疗儿童变应性鼻炎疗效的随机对照试验(RCT)符合纳入标准。主要评估中药对鼻痒的疗效。采用偏倚风险工具2.0评估偏倚风险。使用RevMan 5.3和Stata/SE 12进行统计分析。采用GRADEpro 3.6评估证据质量。采用风险比(RR)及相应的95%置信区间(CI)评估和呈现二分数据,而采用均数差(MD)和标准化均数差(SMD)处理连续性数据。当数据显示同质性(I²>0.1,I²<50%)时,应用固定效应模型;而异质性数据则采用随机效应模型。以P值<0.05确定统计学显著性。本研究遵循系统评价和Meta分析的首选报告项目(PRISMA)指南进行,其综述方案已在国际注册系统评价和Meta分析计划平台(INPLASY202340076)上注册。该综述纳入了23项研究。Meta分析表明,中药与鼻痒减轻显著相关(MD=-0.59,95%CI:-0.94至-0.24),且与白细胞介素10水平升高相关(SMD=1.47,95%CI:0.90至2.05)。与西药相比,中药联合西药在缓解鼻痒、抑制免疫球蛋白E、白细胞介素4和33、提高白细胞介素10水平、提高治疗效率及减少复发方面疗效更佳。口服中药治疗鼻痒更有效(MD=-0.45,95%CI:-0.62至-0.29)。口服与外用中药联合治疗鼻痒更有效(MD=-0.44,95%CI:-0.54至-0.33),可抑制免疫球蛋白E、白细胞介素4(SMD=-0.87,95%CI:-1.24至-0.50)和33(SMD=-1.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d028/10482051/398674c625fb/fphar-14-1240917-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d028/10482051/91fda5f94c71/fphar-14-1240917-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d028/10482051/dce9535c58e6/fphar-14-1240917-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d028/10482051/802f3ad7e0ee/fphar-14-1240917-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d028/10482051/61e1faa26e84/fphar-14-1240917-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d028/10482051/025ec73f525e/fphar-14-1240917-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d028/10482051/00e54dc078ac/fphar-14-1240917-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d028/10482051/6543d51b3d89/fphar-14-1240917-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d028/10482051/3d0e2ed45fd0/fphar-14-1240917-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d028/10482051/d0885e7eadfc/fphar-14-1240917-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d028/10482051/e3a2d7ea82c4/fphar-14-1240917-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d028/10482051/913cb582d63b/fphar-14-1240917-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d028/10482051/205c3fca62f6/fphar-14-1240917-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d028/10482051/398674c625fb/fphar-14-1240917-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d028/10482051/91fda5f94c71/fphar-14-1240917-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d028/10482051/dce9535c58e6/fphar-14-1240917-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d028/10482051/802f3ad7e0ee/fphar-14-1240917-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d028/10482051/61e1faa26e84/fphar-14-1240917-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d028/10482051/025ec73f525e/fphar-14-1240917-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d028/10482051/00e54dc078ac/fphar-14-1240917-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d028/10482051/6543d51b3d89/fphar-14-1240917-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d028/10482051/3d0e2ed45fd0/fphar-14-1240917-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d028/10482051/d0885e7eadfc/fphar-14-1240917-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d028/10482051/e3a2d7ea82c4/fphar-14-1240917-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d028/10482051/913cb582d63b/fphar-14-1240917-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d028/10482051/205c3fca62f6/fphar-14-1240917-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d028/10482051/398674c625fb/fphar-14-1240917-g013.jpg

相似文献

1
Efficacy of Chinese herbal medicine on nasal itching in children with allergic rhinitis: a systematic review and meta-analysis.中药对儿童过敏性鼻炎鼻痒的疗效:一项系统评价和Meta分析
Front Pharmacol. 2023 Aug 23;14:1240917. doi: 10.3389/fphar.2023.1240917. eCollection 2023.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Efficacy and safety of the Chinese herbal medicine Xiao-qing-long-tang for allergic rhinitis: A systematic review and meta-analysis of randomized controlled trials.中药小青龙汤治疗变应性鼻炎的疗效和安全性:系统评价和随机对照试验的荟萃分析。
J Ethnopharmacol. 2022 Oct 28;297:115169. doi: 10.1016/j.jep.2022.115169. Epub 2022 Mar 4.
4
Efficacy of Chinese herbal medicine in treatment of allergic rhinitis in children: a meta-analysis of 19 randomized controlled trials.中药治疗儿童过敏性鼻炎的疗效:19项随机对照试验的荟萃分析
J Int Med Res. 2018 Oct;46(10):4006-4018. doi: 10.1177/0300060518786905. Epub 2018 Aug 7.
5
The efficacy and safety of Chinese herbal medicine as an add-on therapy for type 2 diabetes mellitus patients with carotid atherosclerosis: An updated meta-analysis of 27 randomized controlled trials.中药作为2型糖尿病合并颈动脉粥样硬化患者辅助治疗的疗效和安全性:27项随机对照试验的更新荟萃分析。
Front Pharmacol. 2023 Mar 23;14:1091718. doi: 10.3389/fphar.2023.1091718. eCollection 2023.
6
Chinese herbal medicine for atopic eczema.用于特应性皮炎的中草药
Cochrane Database Syst Rev. 2013 Sep 10;2013(9):CD008642. doi: 10.1002/14651858.CD008642.pub2.
7
Efficacy and Safety of Chinese Herbal Medicine for Knee Osteoarthritis: Systematic Review and Meta-analysis of Randomized Controlled Trials.中药治疗膝骨关节炎的疗效与安全性:随机对照试验的系统评价与Meta分析
Phytomedicine. 2022 Jun;100:154029. doi: 10.1016/j.phymed.2022.154029. Epub 2022 Mar 6.
8
Chinese herbal medicine for endometriosis.用于治疗子宫内膜异位症的中药
Cochrane Database Syst Rev. 2012 May 16(5):CD006568. doi: 10.1002/14651858.CD006568.pub3.
9
Oral application of Chinese herbal medicine for allergic rhinitis: A systematic review and meta-analysis of randomized controlled trials.中药口服治疗变应性鼻炎的系统评价和荟萃分析:随机对照试验。
Phytother Res. 2021 Jun;35(6):3113-3129. doi: 10.1002/ptr.7037. Epub 2021 Feb 3.
10
Guominjian for allergic rhinitis: A protocol for systematic review and meta-analysis of randomized clinical trials.过敏性鼻炎的“国民健”:一项随机临床试验系统评价与Meta分析方案
Medicine (Baltimore). 2020 Oct 30;99(44):e22854. doi: 10.1097/MD.0000000000022854.

引用本文的文献

1
Traditional Chinese Medicine for Pediatric Allergic Diseases.用于小儿过敏性疾病的中医药
Curr Allergy Asthma Rep. 2025 Jul 31;25(1):33. doi: 10.1007/s11882-025-01208-7.
2
Efficacy and safety of Chinese patent medicines for allergic rhinitis based on 2020 Chinese Pharmacopoeia: a protocol for systematic review and meta-analysis of randomized controlled trials.基于《2020年中国药典》的治疗变应性鼻炎中成药的有效性和安全性:一项随机对照试验的系统评价和Meta分析方案
Syst Rev. 2025 Mar 24;14(1):69. doi: 10.1186/s13643-024-02748-1.
3
A Review of Recent Progress in the Mechanisms and Effectiveness of Acupuncture for Treating Allergic Rhinitis.

本文引用的文献

1
A systematic pharmacology-based in vivo study to reveal the effective mechanism of Yupingfeng in asthma treatment.基于系统药理学的体内研究揭示玉屏风治疗哮喘的有效机制。
Phytomedicine. 2023 Jun;114:154783. doi: 10.1016/j.phymed.2023.154783. Epub 2023 Mar 22.
2
Upper Airway Cough Syndrome.上气道咳嗽综合征。
Otolaryngol Clin North Am. 2023 Feb;56(1):147-155. doi: 10.1016/j.otc.2022.09.011. Epub 2022 Oct 22.
3
Leukotrienes vs. Montelukast-Activity, Metabolism, and Toxicity Hints for Repurposing.白三烯与孟鲁司特——活性、代谢及毒性:重新利用的线索
针刺治疗变应性鼻炎的机制及有效性研究进展综述
Int J Gen Med. 2025 Jan 4;18:1-10. doi: 10.2147/IJGM.S501158. eCollection 2025.
4
V Brazilian Consensus on Rhinitis - 2024.第五届巴西鼻炎共识 - 2024年
Braz J Otorhinolaryngol. 2025 Jan-Feb;91(1):101500. doi: 10.1016/j.bjorl.2024.101500. Epub 2024 Sep 7.
Pharmaceuticals (Basel). 2022 Aug 23;15(9):1039. doi: 10.3390/ph15091039.
4
[Prevalence of allergic rhinitis in Chinese children from 2001 to 2021: Meta analysis].[2001年至2021年中国儿童过敏性鼻炎患病率:Meta分析]
Zhonghua Yu Fang Yi Xue Za Zhi. 2022 Jun 6;56(6):784-793. doi: 10.3760/cma.j.cn112150-20220315-00242.
5
[Guideline for diagnosis and treatment of pediatric allergic rhinitis (2022, revision)].《儿童变应性鼻炎诊断和治疗指南(2022年修订版)》
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2022 Apr 7;57(4):392-404. doi: 10.3760/cma.j.cn115330-20220303-00092.
6
Allergic diseases influence symptom severity and T lymphocyte subgroups of children with tic disorders.过敏性疾病影响抽动障碍儿童的症状严重程度和 T 淋巴细胞亚群。
J Investig Med. 2021 Dec;69(8):1453-1457. doi: 10.1136/jim-2021-001788. Epub 2021 Jul 13.
7
Childhood atopic dermatitis as a precursor for developing attention deficit/hyperactivity disorder.儿童特应性皮炎是导致注意缺陷多动障碍的前兆。
Int J Immunopathol Pharmacol. 2020 Jan-Dec;34:2058738420962902. doi: 10.1177/2058738420962902.
8
Traditional Chinese Medicine (TCM) and Allergic Diseases.中医(TCM)与过敏性疾病。
Curr Allergy Asthma Rep. 2020 Sep 2;20(11):67. doi: 10.1007/s11882-020-00959-9.
9
Does Allergy Break Bones? Osteoporosis and Its Connection to Allergy.过敏会导致骨折吗?骨质疏松症及其与过敏的关系。
Int J Mol Sci. 2020 Jan 21;21(3):712. doi: 10.3390/ijms21030712.
10
Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper.全身性类固醇在鼻炎和鼻窦炎中短期和长期使用的益处与危害:欧洲变态反应和临床免疫学会立场文件
Clin Transl Allergy. 2020 Jan 3;10:1. doi: 10.1186/s13601-019-0303-6. eCollection 2020.